Kikuya Sugiura
Izumisano, 5988531, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Red blood cell differentiation using canine-induced pluripotent stem cells.
Journal: Stem cells translational medicine
Published: October 01, 2025
Canine induced pluripotent stem cells can be successfully maintained in weekend-free culture systems.
Journal: The Journal of veterinary medical science
Published: January 03, 2024
Toll-like receptor 3-stimulation and aggregate-formation synergistically enhances anti-inflammatory activity of feline mesenchymal stem cells.
Journal: Journal of veterinary science
Published: December 30, 2023
Generation of canine induced pluripotent stem cell-derived mesenchymal stem cells: Comparison of differentiation strategies and cell origins.
Journal: Regenerative therapy
Published: November 18, 2023
Generation, characterization, and differentiation of induced pluripotent stem-like cells in the domestic cat.
Journal: The Journal of reproduction and development
Published: October 25, 2023
Generation of canine induced pluripotent stem cells under feeder-free conditions using Sendai virus vector encoding six canine reprogramming factors.
Journal: Stem cell reports
Published: November 14, 2022
Atypical hypoadrenocorticism with intact zona glomerulosa of the adrenal cortex after long-term observation: a case report of a dog.
Journal: The Journal of veterinary medical science
Published: November 13, 2022
Canine induced pluripotent stem cells efficiently differentiate into definitive endoderm in 3D cell culture conditions using high-dose activin A.
Journal: Regenerative therapy
Published: July 30, 2022
Generation of molecular-targeting helix-loop-helix peptides for inhibition of the interaction between cytotoxic T-lymphocyte-associated protein 4 and B7 in the dog.
Journal: The Journal of veterinary medical science
Published: June 26, 2022
Mesenteric lymph node abscesses due to Escherichia coli in a cat.
Journal: Veterinary medicine and science
Published: June 02, 2022
New Class of Drug Modalities: Directed Evolution of a De Novo Designed Helix-Loop-Helix Peptide to Bind VEGF for Tumor Growth Inhibition.
Journal: ACS chemical biology
Published: February 18, 2022
Last Updated: 09/26/2026